The Cochlear Limited (ASX: COH) share price is backtracking on Monday as it trades ex-dividend.
At the time of writing, Cochlear shares are swapping hands for $218.05, down 2.16%.
Below we take a closer look at Cochlear’s latest dividend and when shareholders can expect payment.
Shareholders set eyes on Cochlear interim dividend
Following the company’s half year results, investors are eyeing Cochlear shares as they go ex-dividend today.
Typically, one business day before the record date, the ex-dividend date is when investors must have purchased shares. If the investor does not buy Cochlear shares before this date, the dividend will go to the seller.
Historically, when a company reaches its ex-dividend day, its shares tend to fall in proportion to the dividend paid out. This is because investors tend to sell off the company’s shares after securing the dividend.
When can shareholders expect to be paid?
For those eligible for Cochlear’s interim dividend, shareholders will receive a payment of $1.55 per share on 21 April. Unfortunately, the dividend is unfranked which means investors will miss out on the imputed tax credits.
The latest interim dividend reflects a 35% lift from the $1.15 declared in the prior comparable period.
The payout ratio is 65% of the company’s underlying net profit.
Cochlear share price summary
Since the beginning of 2022, Cochlear shares are around 2% higher in the green.
Cochlear shares reached a 52-week low of $178.55 in January, before surging higher over the following weeks.
Based on today’s price, Cochlear commands a market capitalisation of roughly $14.29 billion and has a trailing dividend yield of 1.17%.
The post Why is the Cochlear (ASX:COH) share price sliding today? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Cochlear right now?
Before you consider Cochlear, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cochlear wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- 3 ASX healthcare shares rated as buys by a leading broker
- Keen to bank the Cochlear (ASX:COH) dividend? Here’s what you need to know
- The Cochlear (ASX:COH) share price has bounced back from the pandemic. Are there more gains to come?
- Cheap ASX share better than Woolworths (ASX:WOW)– and it pays dividends
- The next ASX share ready to join the 20-bagger club: expert
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/gUeMtIw
Leave a Reply